Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 827 entries
Sorted by: Best Match Show Resources per page
A Plurihormonal TSH-Secreting Pituitary Microadenoma: Report of a Case with an Atypical Clinical Presentation and Transient Response to Bromocriptine Therapy.

Endocrine pathology

Zuniga S, Mendoza V, Espinoza IF, Zarate A, Mason M, Mercado M.
PMID: 12114675
Endocr Pathol. 1997;8(1):81-86. doi: 10.1007/BF02739711.

Inappropriate secretion of thyrotropin (TSH) is a rare cause of hyperthyroidism, and it is caused by either a TSH-producing pituitary adenoma (usually a macroadenoma) or to selective pituitary resistance to thyroid hormone. The case of a 31-yr-old male who...

Cite
Zuniga S, Mendoza V, Espinoza IF, et al. A Plurihormonal TSH-Secreting Pituitary Microadenoma: Report of a Case with an Atypical Clinical Presentation and Transient Response to Bromocriptine Therapy. Endocr Pathol. 1997;8(1):81-86doi: 10.1007/BF02739711.
Zuniga, S., Mendoza, V., Espinoza, I. F., Zarate, A., Mason, M., & Mercado, M. (1997). A Plurihormonal TSH-Secreting Pituitary Microadenoma: Report of a Case with an Atypical Clinical Presentation and Transient Response to Bromocriptine Therapy. Endocrine pathology, 8(1), 81-86. https://doi.org/10.1007/BF02739711
Zuniga, Sergio, et al. "A Plurihormonal TSH-Secreting Pituitary Microadenoma: Report of a Case with an Atypical Clinical Presentation and Transient Response to Bromocriptine Therapy." Endocrine pathology vol. 8,1 (1997): 81-86. doi: https://doi.org/10.1007/BF02739711
Zuniga S, Mendoza V, Espinoza IF, Zarate A, Mason M, Mercado M. A Plurihormonal TSH-Secreting Pituitary Microadenoma: Report of a Case with an Atypical Clinical Presentation and Transient Response to Bromocriptine Therapy. Endocr Pathol. 1997;8(1):81-86. doi: 10.1007/BF02739711. PMID: 12114675.
Copy Download .nbib Format: NLM
Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action.

Convulsive therapy

Papakostas Y, Markianos M, Papadimitriou G, Stefanis C.
PMID: 11941070
Convuls Ther. 1990;6(3):214-220.

The effect of electroconvulsive therapy (ECT) on serum thyrotropin (TSH) and prolactin (PRL) was systematically investigated in two studies: a simulated ECT (SECT) versus real ECT controlled design, and one in which a more sensitive TSH assay was used....

Cite
Papakostas Y, Markianos M, Papadimitriou G, et al. Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action. Convuls Ther. 1990;6(3):214-220
Papakostas, Y., Markianos, M., Papadimitriou, G., & Stefanis, C. (1990). Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action. Convulsive therapy, 6(3), 214-220.
Papakostas, Yiannis, et al. "Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action." Convulsive therapy vol. 6,3 (1990): 214-220.
Papakostas Y, Markianos M, Papadimitriou G, Stefanis C. Thyrotropin and Prolactin Secretion During ECT: Implications for the Mechanism of ECT Action. Convuls Ther. 1990;6(3):214-220. PMID: 11941070.
Copy Download .nbib Format: NLM
Thyrotropin-releasing hormone receptor: Its partial purification from bovine anterior pituitary gland and its close association with adenyl cyclase.

FEBS letters

Poirier G, Labrie F, Barden N, Lemaire S.
PMID: 11946438
FEBS Lett. 1972 Feb 15;20(3):283-286. doi: 10.1016/0014-5793(72)80087-5.

No abstract available.

Cite
Poirier G, Labrie F, Barden N, et al. Thyrotropin-releasing hormone receptor: Its partial purification from bovine anterior pituitary gland and its close association with adenyl cyclase. FEBS Lett. 1972;20(3):283-286doi: 10.1016/0014-5793(72)80087-5.
Poirier, G., Labrie, F., Barden, N., & Lemaire, S. (1972). Thyrotropin-releasing hormone receptor: Its partial purification from bovine anterior pituitary gland and its close association with adenyl cyclase. FEBS letters, 20(3), 283-286. https://doi.org/10.1016/0014-5793(72)80087-5
Poirier, G, et al. "Thyrotropin-releasing hormone receptor: Its partial purification from bovine anterior pituitary gland and its close association with adenyl cyclase." FEBS letters vol. 20,3 (1972): 283-286. doi: https://doi.org/10.1016/0014-5793(72)80087-5
Poirier G, Labrie F, Barden N, Lemaire S. Thyrotropin-releasing hormone receptor: Its partial purification from bovine anterior pituitary gland and its close association with adenyl cyclase. FEBS Lett. 1972 Feb 15;20(3):283-286. doi: 10.1016/0014-5793(72)80087-5. PMID: 11946438.
Copy Download .nbib Format: NLM
Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty.

Obesity surgery

Papavramidis ST, Zisiadis AC, Karamouzis MN, Kessissoglou II, Antoniadou HA, Aidonopoulos AP.
PMID: 10733815
Obes Surg. 1995 Aug;5(3):298-301. doi: 10.1381/096089295765557674.

BACKGROUND: Published results of studies of thyroid function in obesity and after weight loss have differed. METHODS: The circulating concentrations of thyroid hormones and TSH were studied in 30 consecutive, euthyroid morbidly obese patients before and after weight loss...

Cite
Papavramidis ST, Zisiadis AC, Karamouzis MN, et al. Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty. Obes Surg. 1995;5(3):298-301doi: 10.1381/096089295765557674.
Papavramidis, S. T., Zisiadis, A. C., Karamouzis, M. N., Kessissoglou, I. I., Antoniadou, H. A., & Aidonopoulos, A. P. (1995). Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty. Obesity surgery, 5(3), 298-301. https://doi.org/10.1381/096089295765557674
Papavramidis, et al. "Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty." Obesity surgery vol. 5,3 (1995): 298-301. doi: https://doi.org/10.1381/096089295765557674
Papavramidis ST, Zisiadis AC, Karamouzis MN, Kessissoglou II, Antoniadou HA, Aidonopoulos AP. Alterations in Thyroid Hormones and Thyrotropin (TSH) in Morbidly Obese Patients before and after Vertical Gastroplasty. Obes Surg. 1995 Aug;5(3):298-301. doi: 10.1381/096089295765557674. PMID: 10733815.
Copy Download .nbib Format: NLM
Multiple pituitary hormone abnormalities, fever, behavioral problems, seizures and apnoic spells in a 6-year old girl.

Hormones (Athens, Greece)

Karavanaki K, Divoli A, Dattani M, Briassoulis G, Theodorou V, Hatzara V, Avlonitis S.
PMID: 17110363
Hormones (Athens). 2002 Apr-Jun;1(2):121-5. doi: 10.14310/horm.2002.1159.

UNLABELLED: A 6-year old girl was examined having two years previously presented a transient Cushing's syndrome, followed by recurrent hyponatremia, attributed to inappropriate ADH secretion (SIADH). The brain MRI showed no abnormalities on repeated examinations, except for a suggestion...

Cite
Karavanaki K, Divoli A, Dattani M, et al. Multiple pituitary hormone abnormalities, fever, behavioral problems, seizures and apnoic spells in a 6-year old girl. Hormones (Athens). 2002;1(2):121-5doi: 10.14310/horm.2002.1159.
Karavanaki, K., Divoli, A., Dattani, M., Briassoulis, G., Theodorou, V., Hatzara, V., & Avlonitis, S. (2002). Multiple pituitary hormone abnormalities, fever, behavioral problems, seizures and apnoic spells in a 6-year old girl. Hormones (Athens, Greece), 1(2), 121-5. https://doi.org/10.14310/horm.2002.1159
Karavanaki, Kyriaki, et al. "Multiple pituitary hormone abnormalities, fever, behavioral problems, seizures and apnoic spells in a 6-year old girl." Hormones (Athens, Greece) vol. 1,2 (2002): 121-5. doi: https://doi.org/10.14310/horm.2002.1159
Karavanaki K, Divoli A, Dattani M, Briassoulis G, Theodorou V, Hatzara V, Avlonitis S. Multiple pituitary hormone abnormalities, fever, behavioral problems, seizures and apnoic spells in a 6-year old girl. Hormones (Athens). 2002 Apr-Jun;1(2):121-5. doi: 10.14310/horm.2002.1159. PMID: 17110363.
Copy Download .nbib Format: NLM
Effects of a single venous dose of zinc on thyroid status in healthy individuals and patients with graves' disease.

Metal-based drugs

Farooqi L, Mazeto GM, Shuhama T, Brandão-Neto J.
PMID: 18475939
Met Based Drugs. 2000;7(3):151-5. doi: 10.1155/MBD.2000.151.

Zinc metabolism may regulate thyroid function acting at TRH (thyrotropin-releasing hormone) synthesis, peripheral deiodination of T4 (tetraiodothyronine), and binding of thyroid hormones to nuclear receptors. The aim of this study was to investigate the effect of acute zinc administration...

Cite
Farooqi L, Mazeto GM, Shuhama T, et al. Effects of a single venous dose of zinc on thyroid status in healthy individuals and patients with graves' disease. Met Based Drugs. 2000;7(3):151-5doi: 10.1155/MBD.2000.151.
Farooqi, L., Mazeto, G. M., Shuhama, T., & Brandão-Neto, J. (2000). Effects of a single venous dose of zinc on thyroid status in healthy individuals and patients with graves' disease. Metal-based drugs, 7(3), 151-5. https://doi.org/10.1155/MBD.2000.151
Farooqi, L, et al. "Effects of a single venous dose of zinc on thyroid status in healthy individuals and patients with graves' disease." Metal-based drugs vol. 7,3 (2000): 151-5. doi: https://doi.org/10.1155/MBD.2000.151
Farooqi L, Mazeto GM, Shuhama T, Brandão-Neto J. Effects of a single venous dose of zinc on thyroid status in healthy individuals and patients with graves' disease. Met Based Drugs. 2000;7(3):151-5. doi: 10.1155/MBD.2000.151. PMID: 18475939; PMCID: PMC2365210.
Copy Download .nbib Format: NLM
Serum concentrations of iodine, thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH) and insulin-like growth factor 1 (IGF-1) during the last trimester of pregnancy, during labour, and in early puerperium of women with normal pregnancy or with intrauterine growth retardation (IUGR).

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Peiker G, Glöckner R, Michels W, Hauck G, Malsch C, Börner A.
PMID: 15511878
J Obstet Gynaecol. 1997 Jun;17(4):340-3. doi: 10.1080/01443619750112754.

In women with intrauterine growth retardation (IUGR), insulin-like growth factor 1 (IGF-1) concentrations tended to reduce during the last trimester of pregnancy. Parameters of thyroid function in maternal serum were not distinctly influenced by IUGR, except for high concentrations...

Cite
Peiker G, Glöckner R, Michels W, et al. Serum concentrations of iodine, thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH) and insulin-like growth factor 1 (IGF-1) during the last trimester of pregnancy, during labour, and in early puerperium of women with normal pregnancy or with intrauterine growth retardation (IUGR). J Obstet Gynaecol. 1997;17(4):340-3doi: 10.1080/01443619750112754.
Peiker, G., Glöckner, R., Michels, W., Hauck, G., Malsch, C., & Börner, A. (1997). Serum concentrations of iodine, thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH) and insulin-like growth factor 1 (IGF-1) during the last trimester of pregnancy, during labour, and in early puerperium of women with normal pregnancy or with intrauterine growth retardation (IUGR). Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 17(4), 340-3. https://doi.org/10.1080/01443619750112754
Peiker, G, et al. "Serum concentrations of iodine, thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH) and insulin-like growth factor 1 (IGF-1) during the last trimester of pregnancy, during labour, and in early puerperium of women with normal pregnancy or with intrauterine growth retardation (IUGR)." Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology vol. 17,4 (1997): 340-3. doi: https://doi.org/10.1080/01443619750112754
Peiker G, Glöckner R, Michels W, Hauck G, Malsch C, Börner A. Serum concentrations of iodine, thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH) and insulin-like growth factor 1 (IGF-1) during the last trimester of pregnancy, during labour, and in early puerperium of women with normal pregnancy or with intrauterine growth retardation (IUGR). J Obstet Gynaecol. 1997 Jun;17(4):340-3. doi: 10.1080/01443619750112754. PMID: 15511878.
Copy Download .nbib Format: NLM
Problems in the diagnosis of pituitary adenoma (Cushing's syndrome) in horses.

New Zealand veterinary journal

Thompson JC, Ellison R, Gillett R, Badcoe L.
PMID: 16031814
N Z Vet J. 1995 Apr;43(2):79-82. doi: 10.1080/00480169.1995.35854.

Thyrotropin releasing hormone (TRH) stimulation tests were carried out on a number of horses, including one clinically affected horse whose age and clinical signs suggested that a pituitary adenoma was most unlikely. The results of these tests indicated that,...

Cite
Thompson JC, Ellison R, Gillett R, et al. Problems in the diagnosis of pituitary adenoma (Cushing's syndrome) in horses. N Z Vet J. 1995;43(2):79-82doi: 10.1080/00480169.1995.35854.
Thompson, J. C., Ellison, R., Gillett, R., & Badcoe, L. (1995). Problems in the diagnosis of pituitary adenoma (Cushing's syndrome) in horses. New Zealand veterinary journal, 43(2), 79-82. https://doi.org/10.1080/00480169.1995.35854
Thompson, J C, et al. "Problems in the diagnosis of pituitary adenoma (Cushing's syndrome) in horses." New Zealand veterinary journal vol. 43,2 (1995): 79-82. doi: https://doi.org/10.1080/00480169.1995.35854
Thompson JC, Ellison R, Gillett R, Badcoe L. Problems in the diagnosis of pituitary adenoma (Cushing's syndrome) in horses. N Z Vet J. 1995 Apr;43(2):79-82. doi: 10.1080/00480169.1995.35854. PMID: 16031814.
Copy Download .nbib Format: NLM
Novel organic nitrate prodrug 4(R)-N-(2-Nitroxyethyl)-2-oxothiazolidine-4-carboxamide (RS-7897) serves as a xenobiotic substrate for pyroglutamyl aminopeptidase I in dogs.

Drug metabolism and pharmacokinetics

Abe K, Yamada M, Terao T, Mizuno H, Matsuoka Y, Yorikane R, Tokui T, Ikeda T.
PMID: 15618758
Drug Metab Pharmacokinet. 2003;18(6):373-80. doi: 10.2133/dmpk.18.373.

RS-7897, a novel organic nitrate, structurally contains aminoethylnitrate (AEN) and L-2-oxothiazolidine-4-carboxylic acid (L-OTCA), which are linked together via an amide bond. Vasodilating activity of RS-7897 was 130 times weaker than that of AEN in vitro, while in vivo it...

Cite
Abe K, Yamada M, Terao T, et al. Novel organic nitrate prodrug 4(R)-N-(2-Nitroxyethyl)-2-oxothiazolidine-4-carboxamide (RS-7897) serves as a xenobiotic substrate for pyroglutamyl aminopeptidase I in dogs. Drug Metab Pharmacokinet. 2003;18(6):373-80doi: 10.2133/dmpk.18.373.
Abe, K., Yamada, M., Terao, T., Mizuno, H., Matsuoka, Y., Yorikane, R., Tokui, T., & Ikeda, T. (2003). Novel organic nitrate prodrug 4(R)-N-(2-Nitroxyethyl)-2-oxothiazolidine-4-carboxamide (RS-7897) serves as a xenobiotic substrate for pyroglutamyl aminopeptidase I in dogs. Drug metabolism and pharmacokinetics, 18(6), 373-80. https://doi.org/10.2133/dmpk.18.373
Abe, Koji, et al. "Novel organic nitrate prodrug 4(R)-N-(2-Nitroxyethyl)-2-oxothiazolidine-4-carboxamide (RS-7897) serves as a xenobiotic substrate for pyroglutamyl aminopeptidase I in dogs." Drug metabolism and pharmacokinetics vol. 18,6 (2003): 373-80. doi: https://doi.org/10.2133/dmpk.18.373
Abe K, Yamada M, Terao T, Mizuno H, Matsuoka Y, Yorikane R, Tokui T, Ikeda T. Novel organic nitrate prodrug 4(R)-N-(2-Nitroxyethyl)-2-oxothiazolidine-4-carboxamide (RS-7897) serves as a xenobiotic substrate for pyroglutamyl aminopeptidase I in dogs. Drug Metab Pharmacokinet. 2003;18(6):373-80. doi: 10.2133/dmpk.18.373. PMID: 15618758.
Copy Download .nbib Format: NLM
Determination of hormones by time-resolved fluoroimmunoassay.

Talanta

Lövgren T, Hemmilä I, Pettersson K, Eskola JU, Bertoft E.
PMID: 18963767
Talanta. 1984 Oct;31(10):909-16. doi: 10.1016/0039-9140(84)80220-9.

Immunoassays based on europium labels and time-resolved fluorescence as the detection method, have been developed. The specific activity of the label is several orders of magnitude higher than that of radioactive labels. Consequently, the technique provides great potential, especially...

Cite
Lövgren T, Hemmilä I, Pettersson K, et al. Determination of hormones by time-resolved fluoroimmunoassay. Talanta. 1984;31(10):909-16doi: 10.1016/0039-9140(84)80220-9.
Lövgren, T., Hemmilä, I., Pettersson, K., Eskola, J. U., & Bertoft, E. (1984). Determination of hormones by time-resolved fluoroimmunoassay. Talanta, 31(10), 909-16. https://doi.org/10.1016/0039-9140(84)80220-9
Lövgren, T, et al. "Determination of hormones by time-resolved fluoroimmunoassay." Talanta vol. 31,10 (1984): 909-16. doi: https://doi.org/10.1016/0039-9140(84)80220-9
Lövgren T, Hemmilä I, Pettersson K, Eskola JU, Bertoft E. Determination of hormones by time-resolved fluoroimmunoassay. Talanta. 1984 Oct;31(10):909-16. doi: 10.1016/0039-9140(84)80220-9. PMID: 18963767.
Copy Download .nbib Format: NLM
Ultradian rhythms in pituitary and adrenal hormones: their relations to sleep.

Sleep medicine reviews

Gronfier C, Brandenberger G.
PMID: 15310510
Sleep Med Rev. 1998 Feb;2(1):17-29. doi: 10.1016/s1087-0792(98)90051-x.

Sleep and circadian rhythmicity both influence the 24-h profiles of the main pituitary and adrenal hormones. From studies using experimental strategies including complete and partial sleep deprivation, acute and chronic shifts in the sleep period, or complete sleep-wake reversal...

Cite
Gronfier C, Brandenberger G. Ultradian rhythms in pituitary and adrenal hormones: their relations to sleep. Sleep Med Rev. 1998;2(1):17-29doi: 10.1016/s1087-0792(98)90051-x.
Gronfier, C., & Brandenberger, G. (1998). Ultradian rhythms in pituitary and adrenal hormones: their relations to sleep. Sleep medicine reviews, 2(1), 17-29. https://doi.org/10.1016/s1087-0792(98)90051-x
Gronfier, C, and Brandenberger, G. "Ultradian rhythms in pituitary and adrenal hormones: their relations to sleep." Sleep medicine reviews vol. 2,1 (1998): 17-29. doi: https://doi.org/10.1016/s1087-0792(98)90051-x
Gronfier C, Brandenberger G. Ultradian rhythms in pituitary and adrenal hormones: their relations to sleep. Sleep Med Rev. 1998 Feb;2(1):17-29. doi: 10.1016/s1087-0792(98)90051-x. PMID: 15310510.
Copy Download .nbib Format: NLM
Inhibited hypothalamic-pituitary-thyroid axis in type I pseudohypoparathyroidism.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Kabadi UM, Cech RP.
PMID: 15251689
Endocr Pract. 1999 Mar-Apr;5(2):61-5. doi: 10.4158/EP.5.2.61.

OBJECTIVE: To assess the hypothalamic-pituitary-thyroid axis in two patients with the diagnosis of type I pseudohypoparathyroidism established previously by characteristic clinical features and laboratory findings, including low serum Ca++, high parathyroid hormone concentration, and subnormal urinary cyclic adenosine monophosphate...

Cite
Kabadi UM, Cech RP. Inhibited hypothalamic-pituitary-thyroid axis in type I pseudohypoparathyroidism. Endocr Pract. 1999;5(2):61-5doi: 10.4158/EP.5.2.61.
Kabadi, U. M., & Cech, R. P. (1999). Inhibited hypothalamic-pituitary-thyroid axis in type I pseudohypoparathyroidism. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 5(2), 61-5. https://doi.org/10.4158/EP.5.2.61
Kabadi, U M, and Cech, R P. "Inhibited hypothalamic-pituitary-thyroid axis in type I pseudohypoparathyroidism." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 5,2 (1999): 61-5. doi: https://doi.org/10.4158/EP.5.2.61
Kabadi UM, Cech RP. Inhibited hypothalamic-pituitary-thyroid axis in type I pseudohypoparathyroidism. Endocr Pract. 1999 Mar-Apr;5(2):61-5. doi: 10.4158/EP.5.2.61. PMID: 15251689.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 827 entries